RINOBEK NASAL SPRAY (beclomethasone dipropionate)

In adolescents and adults: a. In community-acquired lung inflammation (pneumonia), 
b. In acute exacerbation of chronic bronchial inflammation, 
c. In acute bacterial inflammation of the nose and sinuses, 
d. In inflammation of the pharynx / tonsils and pharynx, to. 
...

In adolescents and adults: a. In community-acquired lung inflammation (pneumonia), 
b. In acute exacerbation of chronic bronchial inflammation, 
c. In acute bacterial inflammation of the nose and sinuses, 
d. In inflammation of the pharynx / tonsils and pharynx, to. 
I...

CODACTIV FORT belongs to a group of medicines called "cough suppressants". 
CODACTIV FORT is used for complaints of cough caused by various reasons. (symptomatic) treatment.

Used in following endications:-baldness treatment in men
-hair loss prevention
-acceleration of hair growth

used in following endications:-helps hair follicles to spread and grow
-baldness treatment
-hair loss prevention
-rapid hair growth

used in following endications:-allergic rhinitis
-asthma treatment
The recommended dose is one tablet per day for adults aged 15 years and over.

EMPAGLIFLOZIN FCT 10 MG & 25 MG

23 gr bottle

TADALAFIL + MACITENTAN FCT 40 mg + 10 mg

DOLUTEGRAVIR 50 mg FCT

TENOFOVIR ALAFENAMIDE FCT 25 MG

15 gr, 30 gr, 45 gr Tube

Humanis joins the TURQUALITY Programme

Humanis operates on a human-oriented basis and offers the basic means for healthier living for all. We rely on our innovative powers and agile pharmaceuticals and health products manufacturing capabilities to substantiate our genuine steps toward shaping the future for better health and wellbeing. We materialize innovative ideas around our values, and pledge better health and wellbeing services wherever there are humans.  We aim to grow as a global actor and bring the good around the world by advancing our pharmaceuticals and health products manufacturing capabilities based on technology. We make a difference with our R&D center, and export our products to 50+ countries. We conduct indoor manufacturing operations in a 45.000 sqm area and have a potential utility space of 108.000 sqm, generating up to 330 million units a year.

We successfully completed the EU GMP (European Union Good Manufacturing Practices) audit conducted by the Belgian authorities.

Humanis, manufacturing to European Union standards, becomes the first Turkish company to export pharmaceuticals to China